BACKGROUND: The prevalence of coronary vessel wall alterations in the general population is not known. Therefore, the aim of our study was to determine the prevalence of coronary artery disease in persons in whom the underlying disease was not related to coronary artery disease and could therefore be regarded as a near normal population. METHODS: We included 331 consecutive patients (173 men, 158 women, aged between 40 and 70 years) who were referred for catheter ablation of an accessory pathway (67.4% ) or atrioventricular-node modification (32.6%) and who underwent coronary angiography as part of their routine baseline evaluation before radiofrequency current application. Most of the patients (79%) of this cohort were free of symptoms of coronary artery disease. Based on visual inspection of coronary angiograms in multiple projections, patients were classified to have one-, two- or three-vessel disease if stenoses greater than 50% of lumen diameter were present. In addition, diffuse vessel wall alterations were assessed using two different score systems. RESULTS: The prevalence of coronary artery disease in this near normal population was 7.3%, with a significant difference in coronary asymptomatic (3.8%) vs symptomatic patients (17.1%). Mean levels of total cholesterol and other risk factors were not significantly different in patients with coronary artery disease compared to those without. But levels of low-density lipoprotein (LDL) cholesterol and lipoprotein(a) were significantly higher and high-density (HDL) cholesterol lower in patients with a stenosis or extent score higher than zero compared to a score of zero. The values of all vessel scores evaluating the extent of critical and diffuse coronary vessel alterations were very low in patients affected with coronary artery disease, indicating a low degree of diffuse alteration of the vessel wall. CONCLUSIONS: The prevalence of coronary artery disease with at least one critical stenosis in subjects aged 40-70 years with an average cholesterol level of 238+/-42 mg. dl(-1)is 7.3%. Copyright 2000 The European Society of Cardiology.
BACKGROUND: The prevalence of coronary vessel wall alterations in the general population is not known. Therefore, the aim of our study was to determine the prevalence of coronary artery disease in persons in whom the underlying disease was not related to coronary artery disease and could therefore be regarded as a near normal population. METHODS: We included 331 consecutive patients (173 men, 158 women, aged between 40 and 70 years) who were referred for catheter ablation of an accessory pathway (67.4% ) or atrioventricular-node modification (32.6%) and who underwent coronary angiography as part of their routine baseline evaluation before radiofrequency current application. Most of the patients (79%) of this cohort were free of symptoms of coronary artery disease. Based on visual inspection of coronary angiograms in multiple projections, patients were classified to have one-, two- or three-vessel disease if stenoses greater than 50% of lumen diameter were present. In addition, diffuse vessel wall alterations were assessed using two different score systems. RESULTS: The prevalence of coronary artery disease in this near normal population was 7.3%, with a significant difference in coronary asymptomatic (3.8%) vs symptomatic patients (17.1%). Mean levels of total cholesterol and other risk factors were not significantly different in patients with coronary artery disease compared to those without. But levels of low-density lipoprotein (LDL) cholesterol and lipoprotein(a) were significantly higher and high-density (HDL) cholesterol lower in patients with a stenosis or extent score higher than zero compared to a score of zero. The values of all vessel scores evaluating the extent of critical and diffuse coronary vessel alterations were very low in patients affected with coronary artery disease, indicating a low degree of diffuse alteration of the vessel wall. CONCLUSIONS: The prevalence of coronary artery disease with at least one critical stenosis in subjects aged 40-70 years with an average cholesterol level of 238+/-42 mg. dl(-1)is 7.3%. Copyright 2000 The European Society of Cardiology.
Authors: Hye-Jeong Lee; Young Jin Kim; Jin Hur; Ji Won Lee; Yoo Jin Hong; Hee Yeong Kim; Hyuk-Jae Chang; Tae Hoon Kim; Byoung Wook Choi Journal: Int J Cardiovasc Imaging Date: 2014-01-23 Impact factor: 2.357
Authors: Young Dae Kim; Hye Yeon Choi; Hyun Ji Cho; Myoung Jin Cha; Chung Mo Nam; Sang Won Han; Hyo Suk Nam; Ji Hoe Heo Journal: Yonsei Med J Date: 2010-05 Impact factor: 2.759
Authors: Ramazan Topsakal; Nihat Kalay; Ibrahim Ozdogru; Yakup Cetinkaya; Sema Oymak; Mehmet Gungor Kaya; Ali Dogan; Mehmet Tugrul Inanc; Ali Ergin Journal: Heart Vessels Date: 2009-05-24 Impact factor: 2.037
Authors: Joseph Chiha; Paul Mitchell; Bamini Gopinath; George Burlutsky; Adam Plant; Pramesh Kovoor; Aravinda Thiagalingam Journal: PLoS One Date: 2016-12-22 Impact factor: 3.240
Authors: Joseph Chiha; Paul Mitchell; Bamini Gopinath; Adam J H Plant; Pramesh Kovoor; Aravinda Thiagalingam Journal: Int J Cardiol Heart Vasc Date: 2015-07-30
Authors: Fabrice Prunier; Gwenola Terrien; Yannick Le Corre; Ailea L Y Apana; Loïc Bière; Gilles Kauffenstein; Alain Furber; Arthur A B Bergen; Theo G M F Gorgels; Olivier Le Saux; Georges Leftheriotis; Ludovic Martin Journal: PLoS One Date: 2013-07-23 Impact factor: 3.240
Authors: Jakub Chmiel; Miłosz K Książek; Weronika Stryszak; Paweł Iwaszczuk; Mateusz K Hołda; Grażyna Świtacz; Artur Kozanecki; Piotr Wilkołek; Paweł Rubiś; Grzegorz Kopeć; Piotr Odrowąż-Pieniążek; Tadeusz Przewłocki; Wiesława Tracz; Piotr Podolec; Piotr Musiałek Journal: Postepy Kardiol Interwencyjnej Date: 2018-09-21 Impact factor: 1.426